VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
This Quarter Return
+23.55%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$135M
AUM Growth
+$135M
(+86%)
Cap. Flow
+$51.4M
Cap. Flow
% of AUM
38.13%
Top 10 Holdings %
Top 10 Hldgs %
44.79%
Holding
161
New
7
Increased
113
Reduced
25
Closed
15
Top Buys
| 1 |
ETP
Energy Transfer Partners L.p.
ETP
|
$5.09M |
| 2 |
EEP
Enbridge Energy Partners
EEP
|
$3.39M |
| 3 |
WPZ
Williams Partners L.P.
WPZ
|
$3.33M |
| 4 |
Plains All American Pipeline
PAA
|
$3.25M |
| 5 |
OKS
Oneok Partners LP
OKS
|
$2.89M |
Top Sells
| 1 |
Targa Resources
TRGP
|
$615K |
| 2 |
XNPT
XENOPORT, INC.
XNPT
|
$458K |
| 3 |
Exelixis
EXEL
|
$314K |
| 4 |
MDVN
MEDIVATION, INC.
MDVN
|
$310K |
| 5 |
Theravance Biopharma
TBPH
|
$304K |
Sector Composition
| 1 | Energy | 64.18% |
| 2 | Healthcare | 25.09% |
| 3 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRRA
151
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| – | – |
-448
| Closed | -$121K |
|
|
ACGN
152
DELISTED
Aceragen, Inc. Common Stock
ACGN
| – | – |
-545
| Closed | -$147K |
|
|
INFI
153
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| – | – |
-34,021
| Closed | -$179K |
|
|
PRTK
154
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| – | – |
-14,884
| Closed | -$226K |
|
|
MRTX
155
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| – | – |
-7,828
| Closed | -$168K |
|
|
ARAV
156
DELISTED
Aravive, Inc. Common Stock
ARAV
| – | – |
-3,652
| Closed | -$176K |
|
|
CMRX
157
DELISTED
Chimerix, Inc.
CMRX
| – | – |
-7,232
| Closed | -$37K |
|
|
TVRD
158
Tvardi Therapeutics, Inc. Common Stock
TVRD
$270M
| – | – |
-452
| Closed | -$101K |
|
159
State Street
STT
$32.1B
| – | – |
0
| – | – |
|
160
Ardelyx
ARDX
$1.57B
| – | – |
-12,922
| Closed | -$100K |
|
161
Arbutus Biopharma
ABUS
$753M
| – | – |
-54,471
| Closed | -$225K |
|